STE Earnings Date: Nov 4, 2026 (Estimated) — STERIS plc
NYSE · Healthcare · Medical Devices
Updated
When is STE's next earnings date?
STERIS plc (STE) is expected to report Q2 2027 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $2.67 on revenue of $1.56B.
How did STE do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q1 2027), STERIS plc posted EPS of $2.59 versus the $2.49 estimate, a beat of 3.2%. Revenue was $1.49B against a $1.49B estimate. The stock's 1-day post-earnings move was -0.4%.
How much does STE stock move after earnings?
STE beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 5.2% (up or down) in the day after earnings.
About STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q1 2027 | 2.49 | 2.59 | +3.19% | $1.49B | ✅ Beat | -0.40% | +1.67% | -2.53% |
| 2026-05-11 | Q4 2026 | 2.86 | 2.83 | -1.05% | $1.59B | ❌ Miss | +4.46% | +5.46% | +3.33% |
| 2026-02-04 | Q3 2026 | 2.53 | 2.53 | +0.00% | $1.50B | ➖ Inline | -7.74% | -7.87% | -12.61% |
| 2025-11-05 | Q2 2026 | 2.36 | 2.47 | +4.66% | $1.46B | ✅ Beat | +6.94% | +10.20% | +8.47% |
| 2025-08-06 | Q1 2026 | 2.29 | 2.34 | +2.18% | $1.39B | ✅ Beat | +6.80% | +11.69% | +11.11% |
| 2024-11-06 | Q2 2025 | 2.12 | 2.14 | +0.94% | $1.33B | ✅ Beat | -5.28% | -2.31% | -4.93% |
| 2024-08-06 | Q1 2025 | 1.98 | 2.03 | +2.53% | $1.28B | ✅ Beat | -2.36% | -2.25% | +0.13% |
| 2024-05-08 | Q4 2024 | 2.38 | 2.58 | +8.40% | $1.42B | ✅ Beat | +7.57% | +12.07% | +7.97% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q1 FY27 · $1.49B total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| Service | 50.6% | $755.5M | +7.8% | $652.2M | $679.5M | $700.6M | $714.9M |
| Product | 49.4% | $737.2M | +6.8% | $718.3M | $801.1M | $690.5M | $745.4M |
By region
Q1 FY27 · $1.12B total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 97.4% | $1.09B | +6.3% | $1.00B | $1.08B | $1.03B | $1.08B |
| IRELAND | 2.6% | $29.0M | +28.9% | $24.1M | $38.2M | $22.5M | $27.3M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.